I’ve added a fun and helpful new feature on the right side bar of the blog in the form of a stem cell biotech stock ticker.
The ticker is for some of the most widely held stem and cellular medicine companies. A sample screen shot is shown in this post.
Quite a few stem cell-related stocks could not be added to this ticker for various reasons including ACTC, Mesoblast, CUR, and others. Yahoo has limits on which stocks can be included based on company size and which exchange they are on.
Think I should have included a different panel of stem cell stocks?
Let me know what you think.
2020 update. I took the stock ticker down for various reasons years ago, but now I’m thinking I might put it back up.